Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Vifor Pharma
Pharma
CSL cuts FY26 revenue projection by $600M, writes off $5B
CSL has slashed its revenue projection for the fiscal year from $15.8 billion to $15.2 billion and is taking a $5 billion asset impairment.
Kevin Dunleavy
May 11, 2026 11:30am
CSL details sales slide behind recent leadership transition
Feb 12, 2026 8:29am
Vifor to cut 55 staffers in Pa. amid CSL downsizing effort
Oct 8, 2025 10:45am
CSL Vifor floats £23M offer to end competition probe in UK
Dec 10, 2024 4:11pm
CSL Vifor promises marketing campaign to resolve EU probe
Jul 22, 2024 11:18am
CordenPharma earmarks $981M to boost GLP-1 manufacturing capacity
Jul 16, 2024 10:04am
